Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Dermatology and Therapy
Published in: Dermatology and Therapy 2/2016

Open Access 01-06-2016 | Erratum

Erratum to: Letter from the Editors

Authors: Alan Menter, Richard B. Warren

Published in: Dermatology and Therapy | Issue 2/2016

Login to get access

Excerpt

In the original publication, the second author’s name was incorrectly published as Richard Warren. The correct name should read as “Richard B. Warren”. …
Metadata
Title
Erratum to: Letter from the Editors
Authors
Alan Menter
Richard B. Warren
Publication date
01-06-2016
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 2/2016
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-016-0110-0

Other articles of this Issue 2/2016

Dermatology and Therapy 2/2016 Go to the issue

Original Research

New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Review

Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy

Erratum

Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis

Original Research

How People with Facial Acne Scars are Perceived in Society: an Online Survey

Original Research

CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation

Review

Darwin’s Tubercle: Review of a Unique Congenital Anomaly

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits